All Publications

A. Lalruatfela, P. Biswal, S. K. Behera, S. Biswal, D. K. Behera, J. J. Dash, and B. Mallick,"Cisplatin disrupts OCT1-DNMT1-piRNA epigenetic regulatory axis to suppress GAB2-mediated aggressiveness in OSCC", Archives of Biochemistry and Biophysics, vol.778, no.110756, pp.1-11, Elsevier, April 2026, 10.1016/j.abb.2026.110756       Article

S. Basu, B. Mallick, A. Singh, and M. K. Baig,"Projection of epigenetic markers of type 2 diabetes reveal pancreatic cancer prognostic tumour states", in 2026 IEEE International Conference for Convergence in Computing Technology (I3CTCON), IEEE, Lonavala, India, March 2026, View Details       Inproceedings

S. K. Behera, A. Lalruatfela, S. Biswal, P. Biswal, J. J. Dash, D. K. Behera, and B. Mallick,"KLF5-mediated transcriptional activation of miR-203a inhibits EMT and increases cisplatin sensitivity by targeting SNAI2 in tongue cancer", Archives of Biochemistry and Biophysics, vol.782, Elsevier, May 2026, 10.1016/j.abb.2026.110845       Article

S. Biswal, J. J. Dash, J. Patra, P. Biswal, A. Lalruatfela, S. Sahoo, Sri. S. Mishra, S. K. Behera, D. K. Behera, M. Nehra, R. Pangi, and B. Mallick,"Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer", Computational Biology and Chemistry, vol.124, no.2, pp.109211, Elsevier, June 2026, 10.1016/j.compbiolchem.2026.109211       Article

P. Biswal, S. Biswal, B. Behura, J. J. Dash, D. K. Behera, S. K. Behera, A. Lalruatfela, and B. Mallick,"microRNA-203a-3p sensitizes cisplatin through disruption of RAN-dependent RRM2 nuclear localization and mitochondrial stress readouts", Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1869, no.195166, pp.1-20, Elsevier, September 2026, 10.1016/j.bbagrm.2026.195166       Article

S. Biswal, S. Biswal, B. Mallick, and B. K. Biswal,"PLK1 inhibition by Shikonin attenuates oral cancer growth through ß-catenin-mediated regulation of EMT and apoptosis", Cellular Signaling, vol.138, Elsevier, February 2026, 10.1016/j.cellsig.2025.112262.       Article

S. Chahal, A. Debnath, H. Jain, R. K. Singh, S. Biswal, B. Mallick, A. Mishra, and P. Siwach,"Targeting EGFR in cancer using terminalia arjuna: an integrated in silico, molecular dynamics, experimental validation, and network pharmacology study", Computational Biology and Chemistry, vol.125, no.109336, pp.1-16, Elsevier, August 2026, https://doi.org/10.1016/j.compbiolchem.2026.109336       Article

T. Chattopadhyay, P. Biswal, S. Biswal, and B. Mallick,"A piRNA chemosensitizes doxorubicin in tongue squamous cell carcinoma by targeting FDFT1 and inhibiting the EIF3H/HIF1a/CYPOR axis", Archives of Biochemistry and Biophysics, vol.770, no.110455, pp.1-17, Elsevier, August 2025, 10.1016/j.abb.2025.110455       Article

A. Lalruatfela, P. Biswal, S. K. Behera, S. Biswal, J. J. Dash, D. K. Behera, and B. Mallick,"Silent guardians gone rogue: the role of PIWI and piRNA in malignant transformation", IUBMB Life, vol.77, no.11, pp.1-19, Wiley, November 2025, 10.1002/iub.70077       Article

P. Biswal and B. Mallick,"miR-185–5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9", DNA Repair, vol.142, no.103750, pp.1-15, Elsevier, October 2024, 10.1016/j.dnarep.2024.103750       Article